Trials / No Longer Available
No Longer AvailableNCT03265171
A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous
A Single-patient Study of Repeat-dose Administration of ProMetic Plasminogen (Human) Intravenous Infusion in an Adult With Hypoplasminogenemia
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Prometic Biotherapeutics, Inc. · Industry
- Sex
- All
- Age
- 16 Months
- Healthy volunteers
- —
Summary
These are single-patient studies with repeat-dose administration of ProMetic Plasminogen IV infusion in one adult and one child with hypoplasminogenemia. These patients are under treatment to address wound healing and obstructions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Plasminogen (Human) |
Timeline
- First posted
- 2017-08-29
- Last updated
- 2020-04-24
Source: ClinicalTrials.gov record NCT03265171. Inclusion in this directory is not an endorsement.